PHASE-I TRIAL WITH CARBETIMER GIVEN ON A 5 DAY SCHEDULE

被引：0
|
作者：
TOUEINI, E [1 ]
DODION, P [1 ]
DEVALERIOLA, D [1 ]
CRESPEIGNE, N [1 ]
PICCART, M [1 ]
RIES, F [1 ]
HOCHSTER, H [1 ]
KENIS, Y [1 ]
机构：
[1] INST JULES BORDET,B-1000 BRUSSELS,BELGIUM
来源：
INVESTIGATIONAL NEW DRUGS | 1987年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [1] PHASE-I TRIAL OF A 5-DAY COURSE OF CARBETIMER
    GRUNBERG, SM
    EHLER, E
    FRANCIS, RB
    MITCHELL, MS
    INVESTIGATIONAL NEW DRUGS, 1990, 8 : S41 - S49
  • [2] CHLOROZOTOCIN - PHASE-I TRIAL OF 5-DAY SCHEDULE
    ANDERSON, T
    FISHER, R
    BARLOCK, A
    YOUNG, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 356 - 356
  • [3] PHASE-I TRIAL OF TAXOTERE - 5-DAY SCHEDULE
    PAZDUR, R
    NEWMAN, RA
    NEWMAN, BM
    FUENTES, A
    BENVENUTO, J
    BREADY, B
    MOORE, D
    JAIYESIMI, I
    VREELAND, F
    BAYSSAS, MMG
    RABER, MN
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (23) : 1781 - 1788
  • [4] PHASE-I STUDY OF CARBOPLATIN GIVEN ON A 5-DAY INTRAVENOUS SCHEDULE
    ROZENCWEIG, M
    NICAISE, C
    BEER, M
    CRESPEIGNE, N
    VANRIJMENANT, M
    LENAZ, L
    KENIS, Y
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (10) : 621 - 626
  • [5] PHASE-I STUDY OF TRIGLYCIDYLURAZOL GIVEN ON A 5-DAY IV SCHEDULE
    NICAISE, C
    ROZENCWEIG, M
    CRESPEIGNE, N
    DODION, P
    GERARD, B
    LAMBERT, M
    DECOSTER, G
    KENIS, Y
    CANCER TREATMENT REPORTS, 1986, 70 (05): : 599 - 603
  • [6] PHASE-I CLINICAL-TRIAL OF CARBETIMER
    HANAUSKE, AR
    MELINK, TJ
    HARMAN, GS
    CLARK, GM
    CRAIG, JB
    KOELLER, JM
    BOLDT, DH
    KANTOR, B
    KISNER, DL
    ORCZYK, G
    ANDERSON, DW
    PAGET, E
    SAROSY, GA
    VONHOFF, DD
    CANCER RESEARCH, 1988, 48 (18) : 5353 - 5357
  • [7] PHASE-I CLINICAL-TRIAL WITH CARBETIMER
    DODION, P
    DEVALERIOLA, D
    BODY, JJ
    HOUA, M
    NOEL, P
    ABRAMS, J
    CRESPEIGNE, N
    WERY, F
    KENIS, Y
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02): : 279 - &
  • [8] A PHASE-I TRIAL OF PCNU (NSC 95466) ON A 5-DAY SCHEDULE
    EARHART, RH
    KOELLER, JM
    DAVIS, HL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 356 - 356
  • [9] A PHASE-I TRIAL OF SPIROGERMANIUM GIVEN BY INFUSION ON A MULTIPLE DOSING SCHEDULE
    BUDMAN, DR
    SCHULMAN, P
    VINCIGUERRA, V
    DEGNAN, T
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 362 - 362
  • [10] PHASE-I CLINICAL-TRIAL OF CARBOPLATIN (CBDCA) ADMINISTERED AT A 5-DAY SCHEDULE
    NICAISE, C
    ROZENCWEIG, M
    BEER, M
    PICCART, M
    CRESPEIGNE, N
    APARICIO, LA
    VANRIJMENANT, M
    LENAZ, L
    KENIS, Y
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 164 - 164
12345